Toril Holien
Impact in
- Hematology top 2%
- Multiple Myeloma Research and Treatments
- Molecular Biology top 10%
- TGF-β signaling in diseases
- Protein Degradation and Inhibitors
- Ubiquitin and proteasome pathways
- Protein Tyrosine Phosphatases
Papers in
-
- TGF-β signaling in diseases 12
- Ubiquitin and proteasome pathways 8
- Protein Degradation and Inhibitors 8
- Glycosylation and Glycoproteins Research 4
- Hematology 22
- Multiple Myeloma Research and Treatments 21
- Co-authors
- Anders Sundan (31 shared papers)Anders Waage (18 shared papers)Hanne Hella (12 shared papers)Thea Kristin Våtsveen (8 shared papers)Oddrun Elise Olsen (9 shared papers)Kristine Misund (17 shared papers)Magne Børset (13 shared papers)Erik Martı́nez-Hackert (2 shared papers)
- Journals
- Blood (6 papers)Oncotarget (3 papers)Cell Communication and Signaling (3 papers)Pharmaceutics (2 papers)PLoS ONE (2 papers)
- Partner nations
- NorwayUnited StatesSweden
In The Last Decade
Toril Holien
46 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 83
- Hematology 336
- Molecular Biology 932
- Rheumatology 171
- Oncology 301
- Cancer Research 134
Countries citing papers authored by Toril Holien
This map shows the geographic impact of Toril Holien's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toril Holien with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toril Holien more than expected).
Fields of papers citing papers by Toril Holien
This network shows the impact of papers produced by Toril Holien. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toril Holien. The network helps show where Toril Holien may publish in the future.
Co-authors
The 25 scholars most cited alongside Toril Holien, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 129 | |
| 2 | 2015 | 127 | |
| 3 | 2007 | 85 | |
| 4 | 2013 | 82 | |
| 5 | 2015 | 73 | |
| 6 | 2018 | 72 | |
| 7 | 2017 | 69 | |
| 8 | 2011 | 63 | |
| 9 | 2020 | 62 | |
| 10 | 2016 | 49 | |
| 11 | 2000 | 45 | |
| 12 | 2018 | 42 | |
| 13 | 2015 | 42 | |
| 14 | 2017 | 41 | |
| 15 | 2014 | 40 | |
| 16 | 2009 | 40 | |
| 17 | 2019 | 39 | |
| 18 | 2020 | 38 | |
| 19 | 2011 | 37 | |
| 20 | 2013 | 35 |
About Toril Holien
Toril Holien is a scholar working on Molecular Biology, Hematology, Oncology, Pulmonary and Respiratory Medicine and Rheumatology, having authored 47 papers that have together received 1.5k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (21 papers), TGF-β signaling in diseases (12 papers), Ubiquitin and proteasome pathways (8 papers), Protein Degradation and Inhibitors (8 papers), Glycosylation and Glycoproteins Research (4 papers), Bone health and treatments (4 papers), Photodynamic Therapy Research Studies (3 papers) and Chemokine receptors and signaling (3 papers). The work is most often cited by research in Hematology (336 citations), Molecular Biology (932 citations), Rheumatology (171 citations), Oncology (301 citations) and Cancer Research (134 citations). Toril Holien has collaborated with scholars based in Norway, United States and Sweden. Frequent co-authors include Anders Sundan, Anders Waage, Hanne Hella, Thea Kristin Våtsveen, Oddrun Elise Olsen, Kristine Misund, Magne Børset, Erik Martı́nez-Hackert, Torstein B. Rø and Berit Størdal. Their work appears in journals such as Blood, Oncotarget, Cell Communication and Signaling, Pharmaceutics and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.